A subscription to IJPC provides on-line access to full-text, full-color, printable PDF copies of all issues and individual articles published by the Journal since 1997.

Volume 25, 2021 Articles
Title/Author (Click for Abstract / Details / Purchase)	Issue/​Page View/Buy
PreScription: The NASEM cBHT Report, Part 2 Allen Loyd V Jr	Jan/Feb 2021 Pg. 4
Cleanroom Cleanliness Mulder Kyle	Jan/Feb 2021 Pg. 6-12
Gender Bias in the Treatment of Menopausal Women: I am Hot as Hell and Not Going to Take It Anymore, Part 2 DeRosa Angela	Jan/Feb 2021 Pg. 14-17
Reversing Erectile Dysfunction and Urinary Incontinence After Prostatectomy or Radiotherapy: The Stanley Prostate-Cancer Treatment Protocol McKettrick Greg, Yoch Doug	Jan/Feb 2021 Pg. 18-23
Case Report: The Quest for a Palatable Compounded Metronidazole (Base) Suspension McElhiney Linda F	Jan/Feb 2021 Pg. 24-28
Intravenous Admixture Preparation Considerations, Part 8: Ready-to-Use Preparations Allen Loyd V Jr	Jan/Feb 2021 Pg. 31-38
Calculations Stockton Shelly J	Jan/Feb 2021 Pg. 40
Acetaminophen (Paracetamol) 50 mg/mL in SyrSpend SF pH4 Allen Loyd V Jr	Jan/Feb 2021 Pg. 42
Amlodipine Besylate 0.5-mg/mL to 10-mg/mL in SuspendIt Oral Suspension Allen Loyd V Jr	Jan/Feb 2021 Pg. 43
Clonidine 0.01-mg/mL in Oral Mix and Oral Mix SF Suspension Allen Loyd V Jr	Jan/Feb 2021 Pg. 44
Cyclophosphamide 10 mg/mL in Oral-Plus or Simple Syrup Suspension Allen Loyd V Jr	Jan/Feb 2021 Pg. 45
Diclofenac Sodium 5 mg/mL in SyrSpend SF pH4 Allen Loyd V Jr	Jan/Feb 2021 Pg. 46
Metronidazole 50-mg/mL in Oral Mix and Oral Mix SF Suspension Allen Loyd V Jr	Jan/Feb 2021 Pg. 47
Design and Performance of an Inexpensive Water Activity Meter Gilda Sagar S, Schober Joseph M, McPherson Timothy	Jan/Feb 2021 Pg. 48-51
Physical Compatibility of Cefiderocol with Selected Intravenous Drugs During Simulated Y-site Administration Lu Juan, Liu Qiang, Kupiec Thomas C, Vail Herbert, Lynch Leslie R, Fam David S, Vu Nicole T	Jan/Feb 2021 Pg. 52-61
Formulation and Pharmaceutical Evaluation of Extemporaneous α-arbutin Creams for the Treatment of Melasma Teeranachaideekul Veerawat, Boonsongsawat Worrawee, Asanawittaya Waralee, Jintapattanakit Anchalee, Chantasart Doungdaw, Wongrakpanich Amaraporn	Jan/Feb 2021 Pg. 62-72
Beyond-use Date of Trimix: A Reproducible Stability Study Using Bracketing Design Patel Gopesh, Davis Countaney, Liu Yi, Ip Kendice, Debideen Krystal E, Anderson Stephanie, Byrne Robert, Herr Dylan, Rhoads Melissa Merrell, Caputo Ross, Banov Daniel, Bassani August S	Jan/Feb 2021 Pg. 73-81
Physical-chemical Stability of Compounded Sildenafil 100-mg Rapid-dissolving Tablets Cheung Matthew, Zhao Fang, Dave Vivek S	Jan/Feb 2021 Pg. 82-87
PreScription: The Past (-->2020), The Present, and The Future (2021-->) Allen Loyd V Jr	Mar/Apr 2021 Pg. 92
The Stanley Prostate-cancer Treatment Protocol for Erectile Dysfunction After Prostatectomy and/or Radiotherapy: A Case Report McKettrick Greg, Yoch Doug	Mar/Apr 2021 Pg. 94-98
Compounding Pearls -- Wound Care: Drugs and Formulations for Dermal Healing Riepl Mike	Mar/Apr 2021 Pg. 100-103
Experimental Multidisciplinary Approach Based on Compounded Capsule's Quality Evaluation for Pharmacy Undergraduate Courses dos Santos Matheus Skrcek Ribeiro, de Lima Amanda Muniz dos Santos, Christoff Adriana de Oliveira, Teixeira Mariana Lopes, Carneiro Jaqueline	Mar/Apr 2021 Pg. 104-108
Descriptive Report of Individual State Responses to Personal Protective Equipment Shortages for Pharmacy Practice During the Covid-10 Pandemic Roberts Patricia A, Eberwein Samuel M, Youmans Danielle, Amerine Lindsey B	Mar/Apr 2021 Pg. 109-113
Quality Control: Minor Chapters, Major Impacts: What United States Pharmacopeia Chapters <51>, <61>, <62>, and <1207> Mean for Your Compounding Practice Kelley Brian	Mar/Apr 2021 Pg. 115-124
Basics of Compounding: Excipients Used in Nonsterile Compounding, Part 8: Humectants Allen Loyd V Jr	Mar/Apr 2021 Pg. 126-128
Intravenous Admixture Preparation Considerations, Part 9-A: Error Prevention in Intravenous Admixture Preparation Allen Loyd V Jr	Mar/Apr 2021 Pg. 131-139
Calculations Stockton Shelly J, Bui Phi H	Mar/Apr 2021 Pg. 140-141
Amlodipine 1-mg/mL in Oral Mix Suspension Allen Loyd V Jr	Mar/Apr 2021 Pg. 142
Canine Soft Chew Base (Veterinary) Allen Loyd V Jr	Mar/Apr 2021 Pg. 143
Eslicarbazepine Acetate 40-mg/mL in Ora-Plus with Ora-Sweet or Ora-Sweet SF Suspension Allen Loyd V Jr	Mar/Apr 2021 Pg. 144
Levodopa/Carbidopa 5.0/1.25 mg/mL in SyrSpend SF pH4 Allen Loyd V Jr	Mar/Apr 2021 Pg. 145
In Vitro Permeability, Irritability, and Release Evaluation of Commonly Used Topical Diclofenac Gel Preparations (1%, 5%, and 10%) Kohan Hamed Gilzad, Baker David M, Sani Shabnam, Bielecki-Wilken Kathleen A, Ramirez Alfonso	Mar/Apr 2021 Pg. 146-155
Stability of Fagron's Phytobase Cream Compounded with Various Hormones Wynn Tom, Taylor Sarah, Zander Clark	Mar/Apr 2021 Pg. 156-162
Stability of Extemporaneously Compounded Nadolol 10-mg/mL Suspension in Oral Mix in Glass and Plastic Bottles and Plastic Syringes Walsh Andrea, Ziegler Blake, Lingertat-Walsh Karen, Law Shirley, Walker Scott E	Mar/Apr 2021 Pg. 163-168
Physicochemical and Microbiological Stability of Compounded Metronidazole Suspensions in PCCA SuspendIt Pramar Yashoda V, Mandal Tarun K, Bostanian Levon A, Le Giang, Morris Tommy C, Graves Richard A	Mar/Apr 2021 Pg. 169-175
PreScription: The Ethical Pharmacist Allen Loyd V Jr	May/Jun 2021 Pg. 180
Pharmacy Technicians' Perceptions of Risk Reduction Strategies Implemented in Response to the Repetitive Strain Injury Associated with Sterile Compounding Zamani Mazdak, Chan Kayin, Wilcox Julie	May/Jun 2021 Pg. 182-186
Insurance Considerations for the Pharmacy Professional Jones Kirsten	May/Jun 2021 Pg. 190-195
A Simplified Method for Compounding Lidocaine Topical Gel: A Demonstration of Quality Assurance to Prevent Errors in 503A Pharmacies Hall Essence, Levesque Dan, Rashid Mamoon, Mullins Randy, Hossain Mohammad Faisal	May/Jun 2021 Pg. 197-204
FDA-funded Report on Compounded Hormones is Tainted, Analysis Shows Brunner Scott	May/Jun 2021 Pg. 206-209
Quality Control: Testing for "Micromonsters": Viable Air and Surface Sampling in Aseptic Compounding Mulder Kyle	May/Jun 2021 Pg. 211-216
Basics of Compounding: Excipients Used in Nonsterile Compounding: Diluents Allen Loyd V Jr	May/Jun 2021 Pg. 218-221
Intravenous Admixture Preparation Considerations, Part 9-B: Error Prevention in Intravenous Admixture Preparation Allen Loyd V Jr	May/Jun 2021 Pg. 222-229
Calculations Stockton Shelly J	May/Jun 2021 Pg. 230-231
Levofloxacin 50-mg/mL in Ora-Plus and Strawberry Syrup Suspension Allen Loyd V Jr	May/Jun 2021 Pg. 232
Naltrexone Hydrochloride 0.5 mg/mL and 5.0 mg/mL in SuspendIt Suspension Allen Loyd V Jr	May/Jun 2021 Pg. 233
Tacrolimus 0.5 mg/mL in Ora-Plus and Simple Syrup Suspension Allen Loyd V Jr	May/Jun 2021 Pg. 234
Temozolomide 10 mg/mL in Oral Mix SF Suspension Allen Loyd V Jr	May/Jun 2021 Pg. 235
Stability Evaluation of Minoxidil in FOAMIL Foam Base with Bracketing Study Design Lupatini Rodrigo, Sidhu Raman, Patel Harshad, Bichar Katia	May/Jun 2021 Pg. 236-240
In Vitro Release Tests of Ketoprofen from Pluronic Lecithin Organogel versus Lipoderm Using Immersion Cells and the Phoenix DB-6 Dry Heat Diffusion Tester McKinney Rachael D, Dunbar Jacob R	May/Jun 2021 Pg. 241-245
Prolonged In-use Stability of Diluted Atezolizumab in Commercial Intravenous Bags Hui Ada, Yin Jian, Liu Wei, Zheng Kai	May/Jun 2021 Pg. 246-257
Study on the Optimal Conditions for Long-term Storage of Melatonin Powder as an In-hospital Preparation Odanaka Keita, Kojima Hiroki, Nakagawa Naoto	May/Jun 2021 Pg. 258-262
PreScription: Endemics, Epidemics, and Pandemics Allen Loyd V Jr	Jul/Aug 2021 Pg. 268
Growing a Compounding Practice: Successful Marketing to Underserved Populations McKettrick Greg, Yoch Doug	Jul/Aug 2021 Pg. 270-274
Expecting the Expected: Planning Considerations for Cleanroom Construction Roberts Patricia A, Kroon Laura	Jul/Aug 2021 Pg. 276-281
Compounding Pearls -- Wound Care: Drugs and Formulations for Dermal Healing, Part 2 Riepl Mike	Jul/Aug 2021 Pg. 282-287
Safety Aspects of Extemporaneous Prescriptions Prescribed by Latvian Healthcare Specialists Kiselova Olga, Maurina Baiba, Sidlovska Venta	Jul/Aug 2021 Pg. 288-295
A Permanent Path for Urgent-use Compounding? APC-supported Legislation Would Allow 503As to Fill Gaps in Coverage When 503Bs Cannot Brunner Scott	Jul/Aug 2021 Pg. 296-297
Quality Control: How to Produce a Well-closed Sealed Vial in a Regulated CGMP Environment: Part 1 Higgins Doral (Neal) O, Prudom Melanie J, Summers Amy	Jul/Aug 2021 Pg. 298-302
Basics of Compounding: Excipients Used in Nonsterile Compounding, Part 10: Rectal Suppository Bases Allen Loyd V Jr	Jul/Aug 2021 Pg. 304-309
Basics of Sterile Compounding: Intravenous Admixture Preparation Considerations, Part 10: Packaging and Container-closure Issues Allen Loyd V Jr	Jul/Aug 2021 Pg. 311-317
Calculations Stockton Shelly J	Jul/Aug 2021 Pg. 318
Apixaban 0.25-mg/mL Suspension for Enteral Feeding Tube Allen Loyd V Jr	Jul/Aug 2021 Pg. 320
Atomoxetine 4-mg/mL Oral Solution/Suspension Allen Loyd V Jr	Jul/Aug 2021 Pg. 321
BHR in PLO Gel (Benadryl, Haldol, and Reglan in Pluronic Lecithin Organogel) Allen Loyd V Jr	Jul/Aug 2021 Pg. 322
Budesonide 0.0.25% Mucoadhesive Gel Allen Loyd V Jr	Jul/Aug 2021 Pg. 323
Cyclopentolate Hydrochloride 0.5%, Phenylephrine HCl 2.5%, and Tropicamide 0.5% Ophthalmic Solution Allen Loyd V Jr	Jul/Aug 2021 Pg. 324
Hydrocortisone 2-mg/mL in Oral Mix Suspension Allen Loyd V Jr	Jul/Aug 2021 Pg. 325
Moh's Paste, Modified Allen Loyd V Jr	Jul/Aug 2021 Pg. 326
Nifedipine 4.mg/mL in SyrSpend SF pH4 Cherry Flavored Allen Loyd V Jr	Jul/Aug 2021 Pg. 327
Tacrolimus 0.1% Topical Microemulsion Allen Loyd V Jr	Jul/Aug 2021 Pg. 328
Valsartan 4-mg/mL in SyrSpend SF pH4 Allen Loyd V Jr	Jul/Aug 2021 Pg. 329
Stability of Dexmedetomidine in Polyvinyl Chloride Bags Containing 0.9% Sodium Chloride Intended for Subcutaneous Infusions Wolfe Amanda, Zhang Jeremy, Lapenskie Julie, Downar James, Kanji Salmaan	Jul/Aug 2021 Pg. 330-335
Compatibility of Estradiol, Estriol, Estrone, Progesterone, and Testosterone Single Formulation in Fitalite, Versatile, or HRT Supreme Cream Base Polonini Hudson C, Dijkers Eli, Ferreira Anderson O, Zander Clark, Taylor Sarah	Jul/Aug 2021 Pg. 336-343
Stability of Compounded Topical Nifedipine in Cream, Gel, and Ointment Bases Teimouri Arezou, Yeung Pollen, Agu Remigius U	Jul/Aug 2021 Pg. 344-351
PreScription: Permissible Exposure Limits and United States Pharmacopeia Chapter <800> Allen Loyd V Jr	Sep/Oct 2021 Pg. 356
Determining Whether a Substance is Legal to Compound with Under Section 503A of the FDCA Cabaleiro Joe	Sep/Oct 2021 Pg. 358-362
Filling the Gaps on the Institute for Safe Medication Practices (ISMP) Do Not Crush List for Immediate-release Products Uttaro Elizabeth, Zhao Fang, Schweighardt Anne	Sep/Oct 2021 Pg. 364-371
Compounding Pearls--Wound Care: Drugs and Formulations for Dermal Healing, Part 3: The Roles of Nitric Oxide, Sildenafil, and Naltrexone Riepl Mike	Sep/Oct 2021 Pg. 372-377
Realities of Pharmaceutical Compounding in the Republic of Uzbekistan Umarov Ulugbek, Zdoryk Oleksandr, Kolisnyk Sergii, Fatkhullaeva Muyussar	Sep/Oct 2021 Pg. 378-384
It's Time for a New Philosophy Brunner Scott	Sep/Oct 2021 Pg. 386-387
Quality Control: How to Produce a Well-closed Sealed Vial in a Regulated CGMP Environment: Part 2 Higgins Doral (Neal) O, Prudom Melanie J, Summers Amy	Sep/Oct 2021 Pg. 389-395
Basics of Compounding: Excipients Used in Nonsterile Compounding, Part 11: Drug Tastes: Innate, Induced, and Improved Allen Loyd V Jr	Sep/Oct 2021 Pg. 396-400
Basics of Sterile Compounding: Intravenous Admixture Preparation, Part 11: Particulate Issues --- Silicone Oil in Vials, Cartridges, and Syringes Allen Loyd V Jr	Sep/Oct 2021 Pg. 403-408
Calculations Stockton Shelly J	Sep/Oct 2021 Pg. 410
Atropine Sulfate 0.1 mg/mL in SyrSpend SF pH4 Oral Suspension Allen Loyd V Jr	Sep/Oct 2021 Pg. 412
Cilazapril 1-mg/mL in Ora-Blend Suspension Allen Loyd V Jr	Sep/Oct 2021 Pg. 413
Clonidine 0.01-mg/mL in Ora-Blend Suspension Allen Loyd V Jr	Sep/Oct 2021 Pg. 414
Dapsone 2-mg/mL in Oral Mix or Oral Mix SF Suspension Allen Loyd V Jr	Sep/Oct 2021 Pg. 415
Dexamethasone 1-mg/mL in Oral Mix or Oral Mix SF Suspension Allen Loyd V Jr	Sep/Oct 2021 Pg. 416
Haloperidol 0.5-mg/mL in SyrSpend SF pH4 Allen Loyd V Jr	Sep/Oct 2021 Pg. 417
Imipramine Hydrochloride 5-mg/mL in SyrSpend SF pH4 Allen Loyd V Jr	Sep/Oct 2021 Pg. 418
Mycophenolate Mofetil 50-mg/mL in Ora-Plus:Cherry Syrup Suspension Allen Loyd V Jr	Sep/Oct 2021 Pg. 419
Sorafenib 20-mg/mL in Oil Oral Suspension Allen Loyd V Jr	Sep/Oct 2021 Pg. 420
Spironolactone 2-mg/mL or 2-5.mg/mL in SyrSpend SF pH4 Allen Loyd V Jr	Sep/Oct 2021 Pg. 421
Compatibility of Gestrinone, Nimesulide, and Piroxicam in Pentravan for Transdermal and Transmucosal Application Polonini Hudson, de Oliveira Ferreira Anderson, Dijkers Eli	Sep/Oct 2021 Pg. 422-426
Stability of Diazepam Enema Extemporaneous Formulation in Manzoni Base Lopalco Antonio, Lopedota Angela, Aurelio Fiorenza, la Forgia Flavia, Fontana Sergio, Franco Massimo, Denora Nunzio	Sep/Oct 2021 Pg. 427-430
Physicochemical and Microbiological Stability of Extemporaneously Compounded Hydrocortisone Oral Suspensions in PCCA Base, SuspendIt Pramar Yashoda V, Mandal Tarun K, Bostanian Levon A, Kader Cyndy, Morris Tommy C, Graves Richard A	Sep/Oct 2021 Pg. 431-439
PreScription: IJPC -- Twenty-Five Year Anniversary Allen Loyd V Jr	Nov/Dec 2021 Pg. 444
Microwave Freeze-thaw Technique for Injectable Drugs: A Review Updated from 1980 to 2021 Hecq Jean-Daniel, Soumoy Laura, Closset Mélanie, Colsoul Marie-Lise, Jamart Jacques, Galanti Laurence	Nov/Dec 2021 Pg. 446-462
Glycopyrrolate Sorbitol Lollipops for Drooling: Two Case Reports Agbi Kelechi E, Carvalho Maria, Vieira-Banov Fabiana	Nov/Dec 2021 Pg. 464-467
Compounding Pearls -- Wound Care: Drugs and Formulations for Dermal Healing, Part 4. Insulin Riepl Mike	Nov/Dec 2021 Pg. 468-472
Hospital Compounding in Nigeria: A Review of Needs, Practice, and Suggestions for Pharmaceutical Dispensing Ciurriculum Development Orubu Ebiowei Samuel F, Patani Bernard Opatimidi, Arhewoh Matthew Ikhuoria	Nov/Dec 2021 Pg. 475-481
Case Reports on the Use of Aloe Vera, Naltrexone, and Topiramate for the Treatment of Scars Harris Kylie, Wright Edward	Nov/Dec 2021 Pg. 482-485
Basics of Compounding: Excipients Used in Nonsterile Compounding, Part 12: Sorbents (Adsorbents and Absorbents) Allen Loyd V Jr	Nov/Dec 2021 Pg. 486-489
Basics of Sterile Compounding: Intravenous Admixture Preparation, Part 12: United States Pharmacopeia Chapters Referenced in the Current United States Pharmacopeia Chapter <797> Pharmaceutical Compounding -- Sterile Preparations Allen Loyd V Jr	Nov/Dec 2021 Pg. 491-496
Calculations Stockton Shelly J	Nov/Dec 2021 Pg. 498
Domperidone 5 mg/mL in SyrSpend SF pH4 Allen Loyd V Jr	Nov/Dec 2021 Pg. 500
Kayexalate in Lactulose Allen Loyd V Jr	Nov/Dec 2021 Pg. 501
Levetiracetam 50 mg/mL in Ora-Sweet and Ora-Plus Suspension Allen Loyd V Jr	Nov/Dec 2021 Pg. 502
Metoprolol Tartrate 10 mg/mL in SyrSpend SF pH4 Oral Suspension Allen Loyd V Jr	Nov/Dec 2021 Pg. 503
Propranolol 2 mg/mL or 5 mg/mL in Ora-Sweet Allen Loyd V Jr	Nov/Dec 2021 Pg. 504
Pyridoxine Hydrochloride 25 mg/mL in Oral Mix and Oral Mix SF Suspension Allen Loyd V Jr	Nov/Dec 2021 Pg. 505
Quetiapine Fumarate 10 mg/mL in Ora-Blend Allen Loyd V Jr	Nov/Dec 2021 Pg. 506
Shari's Burn Cream Allen Loyd V Jr	Nov/Dec 2021 Pg. 507
Sulfadiazine 100 mg/mL in SyrSpend SF pH4 Allen Loyd V Jr	Nov/Dec 2021 Pg. 508
Ziprasidone Mesylate 2.5 mg/mL in Ora-Sweet Suspension Allen Loyd V Jr	Nov/Dec 2021 Pg. 509
Compounding Robots for Intravenous Therapy in European Countries: A Review in 2020 Hecq Jean-Daniel, Soumoy Laura	Nov/Dec 2021 Pg. 510-514
Evaluation of Closed-system Transfer Devices in Reducing Potential Risk for Surface Contamination Following Simulated Hazardous-drug Preparation and Compounding Soefje Scott, Rickabaugh Keith, Rajkumar Rahul, Wall Kathryn P	Nov/Dec 2021 Pg. 515-522
Formulation, Physical Stability, and the Clinical Effectiveness of Extemporaneous Ivermectin Oral Solution Zaid Abdel-Naser, Zaaror Yara Abu, Qaddumi Aiman, Ratrout Ala, Ahmad Ayda, Hamad Emad, Kittana Naim	Nov/Dec 2021 Pg. 523-527
Return to Top